US pharma giant Cosette has offered $7.40 a share for Mayne Pharmaceuticals, a premium to recent trading but a fraction of the $42 it was trading at in 2016.

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to ...

Bridgewater-based Cosette Pharmaceuticals announced Feb. 20 it entered into an agreement to acquire Mayne Pharma Group Ltd. in a $430 million deal. Mayne is an Australian-headquartered specialty ...

Cosette Pharmaceuticals Inc, which is backed by Avista Healthcare Partners and Hamilton Lane, has agreed to acquire Mayne Pharma, an Australian specialty pharmaceutical company, for $430 million.

With a $430 million buyout of Australia’s Mayne Pharma locked down, Cosette Pharmaceuticals is looking to become a leading force in women’s healthcare. The New Jersey-based drugmaker agreed to ...

“Cosette is in the midst of an exciting period of accelerated growth and portfolio expansion, and Brad is the right commercial leader to take our business to the next level,” said Apurva ...

Australia’s leading independent law firm, Corrs Chambers Westgarth, has advised Cosette Pharmaceuticals, Inc (Cosette) on its ...

After six seasons of artistic collaboration, Cosette Justo Valdés will conclude her tenure as Resident Conductor of the Edmonton Symphony Orchestra (ESO) at the end of the 2024/25 concert season.

BRIDGEWATER, N.J., February 20, 2025--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it ...